Aragen Life Sciences Ltd. excels in providing end-to-end drug discovery and development solutions, showcasing its innovative approaches and strong commitment to sustainability and customer satisfaction. SAN ANTONIO , July 24, 2024 /PRNewswire/ -- Frost & Sullivan has recognized Aragen Life Sciences, a world-class contract research, development, and manufacturing organization (CRDMO), with the 2024 Global Customer Value Leadership Award.
With nearly 25 years of experience, Aragen assists its global clients in various industries, such as pharmaceutical, biotech, and agrochemical, throughout the biopharmaceutical lifecycle, offering comprehensive solutions spanning small and large molecules. The company provides highly customized services tailored to meet client requirements and leverages cutting-edge technologies, such as artificial intelligence and machine learning, to drive its discovery and development projects to commercialization. It also focuses on sustainability through initiatives like carbon-neutral programs and green chemistry, underscoring its dedication to environmental responsibility.
Mani Kantipudi , CEO of Aragen Life Sciences, said, "We are honored to receive the 2024 Global Customer Value Leadership Award from Frost & Sullivan. This recognition reflects our relentless pursuit of excellence and innovation in delivering value to our clients. We remain committed to advancing the forefront of drug discovery and development while upholding the highest standards of q.